166 related articles for article (PubMed ID: 1951842)
21. Cutaneous and mammary apocrine carcinomas have different immunoprofiles.
Piris A; Peng Y; Boussahmain C; Essary LR; Gudewicz TM; Hoang MP
Hum Pathol; 2014 Feb; 45(2):320-6. PubMed ID: 24342430
[TBL] [Abstract][Full Text] [Related]
22. Eccrine sweat gland carcinoma: an histologic and immunohistochemical study of 32 cases.
Swanson PE; Cherwitz DL; Neumann MP; Wick MR
J Cutan Pathol; 1987 Apr; 14(2):65-86. PubMed ID: 2439558
[TBL] [Abstract][Full Text] [Related]
23. KIT (CD117) Expression in Benign and Malignant Sweat Gland Tumors.
Nishida H; Daa T; Kashima K; Arakane M; Urabe S; Yoshikawa Y; Gamachi A; Yokoyama S
Am J Dermatopathol; 2015 Dec; 37(12):898-905. PubMed ID: 25634571
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical study of lysozyme in various benign sweat apparatus tumors.
Katsumata M; Ezoe K
J Dermatol; 1990 May; 17(5):307-11. PubMed ID: 2166096
[TBL] [Abstract][Full Text] [Related]
25. Topics in histopathology of sweat gland and sebaceous neoplasms.
Ansai SI
J Dermatol; 2017 Mar; 44(3):315-326. PubMed ID: 28256768
[TBL] [Abstract][Full Text] [Related]
26. Estrogen and progesterone receptors in primary eccrine carcinoma.
Voytek TM; Ricci A; Cartun RW
Mod Pathol; 1991 Sep; 4(5):582-5. PubMed ID: 1661896
[TBL] [Abstract][Full Text] [Related]
27. Expression of Bcl-x in normal skin and benign cutaneous adnexal tumors.
Thamboo TP; Tan LH; Tan SY
J Cutan Pathol; 2006 Jan; 33(1):27-32. PubMed ID: 16441408
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical study of calretinin in normal skin and cutaneous adnexal proliferations.
González-Guerra E; Kutzner H; Rutten A; Requena L
Am J Dermatopathol; 2012 Jul; 34(5):491-505. PubMed ID: 22343111
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.
Gatalica Z
Pathol Res Pract; 1997; 193(11-12):753-8. PubMed ID: 9521507
[TBL] [Abstract][Full Text] [Related]
30. Clear cell eccrine carcinomas of the skin. A clinicopathologic study of nine patients.
Wong TY; Suster S; Nogita T; Duncan LM; Dickersin RG; Mihm MC
Cancer; 1994 Mar; 73(6):1631-43. PubMed ID: 7512435
[TBL] [Abstract][Full Text] [Related]
31. Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases.
Plaza JA; Ortega PF; Stockman DL; Suster S
J Cutan Pathol; 2010 Apr; 37(4):403-10. PubMed ID: 20377670
[TBL] [Abstract][Full Text] [Related]
32. [Contribution of monoclonal antibody D 47 in the study of sweat gland pathology].
Kanitakis J; Schmitt D; Thivolet J
Ann Pathol; 1985; 5(1):19-27. PubMed ID: 2990499
[TBL] [Abstract][Full Text] [Related]
33. Histochemistry of the cutaneous adnexa and selected adnexal neoplasms.
Johnson WC
J Cutan Pathol; 1984 Oct; 11(5):352-6. PubMed ID: 6512066
[No Abstract] [Full Text] [Related]
34. A monoclonal antibody, SKH1, reacts with 40 Kd sweat gland-associated antigen.
Suzuki Y; Hashimoto K; Kato I; Nishioka K; Eto H; Nishiyama S; Kanzaki T
J Cutan Pathol; 1989 Apr; 16(2):66-71. PubMed ID: 2668356
[TBL] [Abstract][Full Text] [Related]
35. Expression of androgen receptors in skin appendage tumors: an immunohistochemical study.
Shikata N; Kurokawa I; Andachi H; Tsubura A
J Cutan Pathol; 1995 Apr; 22(2):149-53. PubMed ID: 7560348
[TBL] [Abstract][Full Text] [Related]
36. Coexpression of cytokeratin and vimentin intermediate filaments in benign and malignant sweat gland tumors.
Eckert F; de Viragh PA; Schmid U
J Cutan Pathol; 1994 Apr; 21(2):140-50. PubMed ID: 7518849
[TBL] [Abstract][Full Text] [Related]
37. Vulvar sweat gland carcinomas.
Wick MR; Goellner JR; Wolfe JT; Su WP
Arch Pathol Lab Med; 1985 Jan; 109(1):43-7. PubMed ID: 2982338
[TBL] [Abstract][Full Text] [Related]
38. Immunoreactivity for Sox10 in Basaloid Neoplasms of The Skin.
Bush JW; Gru AA; Wick MR
Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):114-118. PubMed ID: 30531326
[TBL] [Abstract][Full Text] [Related]
39. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
Tsutsumi Y
Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
[TBL] [Abstract][Full Text] [Related]
40. Abundant expression of neuronatin in normal eccrine, apocrine and sebaceous glands and their neoplasms.
Dugu L; Takahara M; Tsuji G; Iwashita Y; Liu X; Furue M
J Dermatol; 2010 Sep; 37(9):846-8. PubMed ID: 20883377
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
